Pat Garcia-Gonzalez: A Bold Plan to Double Impact and Reach 100,000 Patients by 2031
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, shared a post on LinkedIn:
”I am excited to invite you to our 2026 State of the Organization, a virtual presentation where I’ll share our vision and priorities at The Max Foundation.
In the year ahead, we are deepening our commitment to what matters most: developing a strategy to more than double our impact by reaching 100,000 patients annually by 2031. This is the driving force behind every partnership we build and every innovation we pursue.
During the presentation, I’ll discuss four organizational priorities for the year and what they mean in real world practice. In 2026, we’re building on that foundation and reaching farther than ever before.
I hope you’ll join me to hear more about how, together, we can continue advancing health equity around the world.
Date: February 19, 2026, 8:00 AM PT
Let’s make this a year of bold impact—one patient, one partnership, one breakthrough at a time.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection